NANETTE ALEXANDER: Open Payments
NPI 1568449262 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,936 in 148 payments from 29 companies in 2025. Trend: 2023 $2,715 · 2024 $2,320 · 2025 $2,936
Food & beverage: $2,936
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 42 | $777 |
| AstraZeneca Pharmaceuticals LP | 15 | $326 |
| PFIZER INC. | 12 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $220 |
| GENZYME CORPORATION | 5 | $196 |
| Verona Pharma, Inc. | 7 | $155 |
| ABBVIE INC. | 12 | $149 |
| Novo Nordisk Inc | 5 | $102 |
| Amgen Inc. | 3 | $76 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
Products named: TRELEGY ELLIPTA, DUPIXENT, Ohtuvayre, AIRSUPRA, BREZTRI, NUCALA, GLASSIA, NURTEC ODT.
Industry payments across CT — which companies pay providers there.
